Epileptic medications such as Dilantin, Phenytek and Cerebyx have reportedly caused skin blisters and bleeding for some Asian patients. Following such reports, The FDA has begun to keenly monitor these drugs.
Initial investigation suggests that patients with the gene HLA-B1502 carry an enhanced risk of skin reactions upon use of the said drug. Nearly 10% to 15% of patients who have reported such reactions belong to Asia, especially from China, Thailand, and Malaysia.
UK Researchers Call for Safety Studies of New Anti-epilepsy Drugs for Children
UK researchers are calling for urgent safety studies of newer anti-epilepsy drugs that are being increasingly prescribed for children.
Advertisement
Victims experienced skin reactions few months after commencing medication.
The agency has directed that the drug carbamazepine, sold under brand names of Tegretol and Carbatrol, be closely monitored for skin reactions.
Source: Medindia
SAV
Source: Medindia
SAV
Lawsuits Against Merck's Vioxx Settled With Generous Compensation
Pharma giant Merck & Co will be doling out $4.85bn in compensation for the side effects of its drug Vioxx.
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Drug News
India's First Urinary Incontinence Drug Fesobig may offer Affordable treatment for Overactive Bladder (OAB), a widely prevalent problem among Indian men and women.
Oral anticoagulant drugs, particularly Rivaroxaban presented superior efficacy and safety than warfarin in atrial fibrillation patients with chronic kidney disease.
Patients with hepatitis D virus-related chronic advanced liver disease are treated with an antiviral therapy.
Among people with COVID-19, Paxlovid drug was found to reduce hospitalization and death risk by 90%, revealed study.
Lilly will likely maintain or increase its market share in the insulin space as the average out-of-pocket cost for its insulin products is already below the $35 price cap.